King Faisal Specialist Hospital and Research Centre Apresenta Suas Inovações e Soluções de Saúde na Global Health Exhibition

RIADE, Arábia Saudita, Oct. 29, 2023 (GLOBE NEWSWIRE) — O King Faisal Specialist Hospital and Research Centre (KFSH&RC) está participando como parceiro de saúde estratégico na Global Health Exhibition 2023 de três dias, com início amanhã em Riade.

O hospital, no seu pavilhão da exposição que acompanha o fórum, mostrará suas inovações e soluções de saúde mais proeminentes no âmbito das suas direções estratégicas destinadas a fortalecer sua posição como pioneiro do conhecimento por meio da educação, pesquisa, inovação e prestação de cuidados de saúde com os mais altos níveis de qualidade e segurança.

Sua Excelência Dr. Majid Ibrahim Al Fayyadh, CEO do King Faisal Specialist Hospital and Research Centre, falou sobre o evento: O Reino da Arábia Saudita está trabalhando para consolidar a sua posição como líder global no campo da inovação, promovendo um ecossistema dinâmico que abraça as mais recentes tecnologias, apoiando o futuro dos cuidados de saúde e se estabelecendo como um destino mundial.

O Dr. Majid Ibrahim Al Fayyadh salientou que a participação do KFSH&RC na exposição está alinhada ao contexto do seu compromisso de promover a inovação no setor da saúde, do nível nacional ao global, e de apoiar tudo o que contribui para proporcionar os mais altos níveis de cuidados de saúde e a melhor experiência para o paciente.

O KFSH&RC apresenta aos visitantes da exposição suas várias inovações e soluções de saúde e seu impacto na melhoria dos resultados dos cuidados de saúde e da experiência do paciente, e na melhoria da eficiência operacional em vários campos médicos, incluindo a jornada do paciente, pesquisa biomédica espacial, medicina genômica, gerenciamento de capacidade, produção de medicamentos radio farmacêuticos e tratamento com células T (células CAR-T).

O KFSH&RC está pronto para exibir suas inovações, demonstrando sua liderança na pesquisa espacial biomédica. Isso é ressaltado pela sua liderança na supervisão de quatro experimentos de pesquisa em ciências celulares conduzidos no espaço, solidificando o papel pioneiro do hospital na promoção da inovação internacional. Além disso, o hospital apresentará seu programa de tratamento com reengenharia de células T para pacientes com câncer, um aprimoramento significativo no atendimento médico especializado dentro do Reino. Esse avanço também se traduz na redução dos encargos financeiros e de saúde, uma vez que os pacientes não são mais obrigados a procurar tratamento no exterior.

O KFSH&RC é considerado um dos mais proeminentes do mundo na prestação de cuidados de saúde especializados, um pioneiro em inovação e um centro avançado de pesquisa e educação médica. O hospital também trabalha no desenvolvimento tecnologias médicas e disseminação dos cuidados de saúde em todo o mundo em parceria com as principais instituições locais, regionais e internacionais, para alcançar um serviço de classe mundial nos campos clínico, de pesquisa e educacional.

Informações de Contato:
kfshrc@mcsaatchi.com

Foto deste comunicado disponível em https://www.globenewswire.com/NewsRoom/AttachmentNg/5b3530bb-ea2d-42ee-a358-4c2fe3f8630e

GlobeNewswire Distribution ID 8967950

King Faisal Specialist Hospital and Research Centre Highlights its Space Biomedical Research Journey at the Global Health Exhibition

King Faisal Specialist Hospital and Research Centre Highlights its Space Biomedical Research Journey at the Global Health Exhibition_02

King Faisal Specialist Hospital and Research Centre Highlights its Space Biomedical Research Journey at the Global Health Exhibition_02

RIYADH, Saudi Arabia, Oct. 29, 2023 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital and Research Centre (KFSH&RC) is presenting its pioneering journey and prospects in space biomedical research and its role in enhancing human health at the Global Health Exhibition, where KFSH&RC is also participating as a strategic healthcare partner.

At the Exhibition, KFSH&RC delves into its groundbreaking experience leading four research experiments in cell sciences in space. These experiments encompass testing the immune cell response to inflammation in space, monitoring the activity of thousands of genes in immune cells exposed to inflammation over time, and tracking the changes in the lifespan of ribonucleic acid (mRNA) between space and Earth. Additionally, the pavilion simulates the inflammatory response to drug treatment using an immune cell model to explore its potential applications for prevention and early treatment.

The aim of these research experiments, conducted in collaboration with the Saudi Space Authority, as part of the scientific mission of Saudi astronauts Rayyanah Barnawi and Ali Al-Qarni to the International Space Station (ISS), is to contribute to exploratory research and its applications in space medicine to enhance the safety of space explorers and utilize the knowledge gained for the benefit the patient community globally.

King Faisal Specialist Hospital and Research Centre Highlights its Space Biomedical Research Journey at the Global Health Exhibition

King Faisal Specialist Hospital and Research Centre Highlights its Space Biomedical Research Journey at the Global Health Exhibition

The scientific experiments lasted for four days and were overseen by the research team led by Dr. Khaled Saad Abu Khubrah, Head of the Department of Molecular Biomedicine and Research at KFSH&RC, along with Dr. Wijdan Al-Ahmadi from KFSH&RC and Dr. Edward Hattie from the BioServe Space Technologies Center in Colorado, USA.

KFSH&RC is actively pursuing further research in space biomedical science to gain a more comprehensive understanding of the effects of gravity deficiency and cosmic radiation on the human body. They aim to leverage the unique space environment, which provides opportunities for medical experiments that are not feasible on Earth. This includes studying how cells and tissues grow in microgravity conditions, potentially leading to groundbreaking discoveries in disease treatments and opening new avenues in space medicine.

KFSH&RC is globally renowned for its specialized healthcare services and its leadership in innovation. It stands as an advanced centre for medical research and education, aiming to advance medical technologies and raise the standard of healthcare worldwide through partnerships with prominent local, regional, and international institutions in clinical, research, and educational fields.

Contact information:
kfshrc@mcsaatchi.com

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/78eba5fa-19d6-437c-ab42-c9a09636e91e

https://www.globenewswire.com/NewsRoom/AttachmentNg/c30c198b-dd13-4d48-8b8c-6667eda49b45

GlobeNewswire Distribution ID 8967907

King Faisal Specialist Hospital & Research Centre Achieves Medical Milestone with World’s First Fully Robotic Living Donor Liver Transplant

King Faisal Specialist Hospital & Research Centre Achieves Medical Milestone with World’s First Fully Robotic Living Donor Liver Transplant_02

King Faisal Specialist Hospital & Research Centre Achieves Medical Milestone with World’s First Fully Robotic Living Donor Liver Transplant _ 02

RIYADH, Saudi Arabia, Oct. 29, 2023 (GLOBE NEWSWIRE) — In a historic achievement, the Organ Transplant Center of Excellence (OTCoE) team at King Faisal Specialist Hospital & Research Centre (KFSH&RC) has successfully performed the world’s first fully robotic living donor liver transplant in the Kingdom of Saudi Arabia—a move that solidifies KFSH&RC’s position as a global leader in minimally invasive transplant surgery.

KFSH&RC’s pioneering approach employed state-of-the-art robotic technology to conduct both donor and recipient surgeries with precision and minimal invasiveness, eliminating the need for a hybrid approach. While other centres offer minimally invasive liver transplants using mixed techniques, KFSH&RC is the only centre to complete a fully robotic living donor liver transplant surgery successfully.

This accomplishment represents a significant leap forward in the history of transplantation, a testament to the centre’s commitment to advanced practices that enhance healthcare outcomes, improve the patient experience, and boost hospital operational efficiency. It has also led to a reduction in the risk of complications, recovery time, and the length of hospital stays.

King Faisal Specialist Hospital & Research Centre Achieves Medical Milestone with World’s First Fully Robotic Living Donor Liver Transplant

King Faisal Specialist Hospital & Research Centre Achieves Medical Milestone with World’s First Fully Robotic Living Donor Liver Transplant

As a strategic health partner at the Global Health Exhibition held in Riyadh from October 29 to October 31, KFSH&RC is showcasing its latest innovations at the forum. Attendees will gain insights into the OTCoE’s expertise in applying cutting-edge technologies to expand healthcare possibilities.

KFSH&RC has set records in successfully conducting reciprocal kidney transplants, a medical approach that facilitates kidney transplants between two donors from different families simultaneously. In 2022, the program achieved a remarkable milestone by completing 91 reciprocal transplants, surpassing its international counterparts.

KFSH&RC’s OTCoE is a pioneer in the Kingdom, representing one of the most advanced and comprehensive facilities for multi-organ transplantation in the Middle East. Its services encompass kidney, liver, lung, pancreas, and intestine transplants, collectively called solid organ transplantation.

KFSH&RC is globally renowned for its exceptional contributions to specialized healthcare, commitment to innovation, and dedication to advanced medical research and education. Furthermore, KFSH&RC is steadfast in its pursuit of developing medical technologies and elevating the standard of healthcare globally by collaborating with major local, regional, and international institutions. It is committed to delivering world-class clinical, research, and educational services.

Contact information:
kfshrc@mcsaatchi.com

Photos accompanying this announcement are available at https://www.globenewswire.com/NewsRoom/AttachmentNg/888a9b0a-3cd2-4186-ab5e-b44eb8f0d9cb

https://www.globenewswire.com/NewsRoom/AttachmentNg/250c97ba-0d78-4a24-83a5-73e063b3366b

GlobeNewswire Distribution ID 8967901

King Faisal Specialist Hospital and Research Centre Showcases its Health Innovations and Solutions at the Global Health Exhibition

King Faisal Specialist Hospital and Research Centre Showcases its Health Innovations and Solutions at the Global Health Exhibition

King Faisal Specialist Hospital and Research Centre Showcases its Health Innovations and Solutions at the Global Health Exhibition

RIYADH, Saudi Arabia, Oct. 28, 2023 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital and Research Centre (KFSH&RC) is participating as a strategic health partner in the Global Health Exhibition 2023, which begins in Riyadh tomorrow and continues for three days.

The hospital, through its pavilion participating in the exhibition accompanying the forum, will showcase its most prominent innovations and health solutions within the framework of its strategic directions aimed at strengthening its position as a pioneer of knowledge through education, research, innovation, and providing health care with the highest levels of quality and safety.

His Excellency the CEO of King Faisal Specialist Hospital and Research Centre, Dr. Majid Ibrahim Al Fayyadh, stated on this occasion: The Kingdom of Saudi Arabia is working to consolidate its position as a global leader in the field of innovation, fostering a dynamic ecosystem that embraces the latest technologies, supporting the future of healthcare, and establishing it as a worldwide destination.

Dr Majid Ibrahim Al Fayyadh stressed that KFSH&RC’s participation in the exhibition comes in the context of its commitment to advancing innovation in the health sector from the national to the global level and supporting everything that contributes to providing the highest levels of healthcare and the best patient experience.

KFSH&RC introduces visitors of the exhibition to its various health innovations and solutions and their impact on enhancing health care outcomes and patient experience and improving operating efficiency in multiple medical fields, including the patient journey, space biomedical research, genomic medicine, capacity management, radiopharmaceutical drug production, and treatment, with T cells (CAR-T Cell).

KFSH&RC is poised to exhibit its innovations, demonstrating its leadership in biomedical space research. This is underscored by its leadership in overseeing four research experiments in cell sciences conducted in space, solidifying the hospital’s pioneering role in fostering international innovation. Additionally, the hospital will present its T-cell re-engineering treatment program for cancer patients, signifying a significant enhancement in specialized medical care within the Kingdom. This advancement also translates to reduced financial and health burdens, as patients are no longer required to seek treatment abroad.

KFSH&RC is considered among the most prominent in the world in providing specialized health care, a pioneer in innovation, and an advanced medical research and education center. It also seeks to develop medical technologies and raise health care worldwide in partnership with major local, regional, and international institutions, to achieve world-class service in the clinical, research, and educational fields.

Contact information:
kfshrc@mcsaatchi.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5b3530bb-ea2d-42ee-a358-4c2fe3f8630e

GlobeNewswire Distribution ID 8967812

eXp Realty incite les équipes à la rejoindre avec une nouvelle incitation à base d’actions

Le programme « Thrive est conçu pour attirer les équipes culturellement alignées

BELLINGHAM, Washington, 27 oct. 2023 (GLOBE NEWSWIRE) — eXp Realty®, cabinet de courtage immobilier le plus axé sur les agents de la planète (« the most agent-centric real estate brokerage on the planet™ »), et filiale principale d’eXp World Holdings, Inc. (Nasdaq : EXPI), se réjouit d’annoncer le lancement de son nouveau programme Thrive, visant à inciter les équipes de production culturellement alignées à rejoindre la famille eXp Realty.

Une fois intégré, sur la base de sa production au cours des 12 mois précédents, le chef d’équipe recevra des actions, soumises à une acquisition future.

« En tant que société déterminée à repousser continuellement les limites en faveur du soutien de nos agents, eXp Realty est toujours à la recherche de nouveaux moyens d’améliorer l’expérience des agents », a déclaré Michael Valdes, directeur de la croissance chez eXp Realty. « Plus tôt cette année, nous avons lancé deux programmes d’incitation, Boost et Accelerate, destinés à aider les maisons de courtage indépendantes et les agents individuels à faire la transition vers eXp Realty. Maintenant, avec l’ajout de Thrive, nous offrons aux équipes une opportunité d’obtenir des actions de manière accélérée. Nous savons que chaque équipe a une culture et une méthode de travail qui lui sont propres, et nous souhaitons proposer une plateforme qui permettra à chacune de prospérer dans notre environnement centré sur les agents. »

eXp Realty fournira cette incitation à base d’actions aux chefs d’équipes culturellement alignées comptant plus de 10 agents, sans compter le chef d’équipe, et un chiffre d’affaires d’un minimum de 40 millions USD/CAD dans le pays d’origine au cours de la période fiscale de 12 mois précédente. Les qualifications internationales seront publiées par la suite. Des qualifications additionnelles s’appliquent. Un critère clé de ce programme consiste en ce que les chefs d’équipe doivent s’engager à former leur équipe et à s’assurer que ses membres s’intègrent à l’écosystème eXp Realty dans le cadre de leur alignement culturel avec eXp.

Le programme d’incitation Thrive se déploie aux États-Unis et au Canada avec effet immédiat et sera bientôt disponible sur 22 marchés mondiaux additionnels d’eXp, sous réserve de la loi en vigueur. Pour en savoir plus sur le nouveau programme Thrive d’eXp Realty et sur la façon dont il peut bénéficier à votre équipe, veuillez cliquer ici.

À propos d’eXp World Holdings, Inc.

eXp World Holdings, Inc. (Nasdaq : EXPI) est la société holding d’eXp Realty®, Virbela® et SUCCESS® Enterprises.

eXp Realty est la plus grande société immobilière indépendante dans le monde avec plus de 89 000 agents aux États-Unis, au Canada, au Royaume-Uni, en Australie, en Afrique du Sud, en Inde, au Mexique, au Portugal, en France, à Porto Rico, au Brésil, en Italie, à Hong Kong, en Colombie, en Espagne, en Israël, au Panama, en Allemagne, en République dominicaine, en Grèce, en Nouvelle-Zélande, au Chili, en Pologne et à Dubaï, et elle continue de se développer à l’échelle internationale. En tant que société cotée en bourse, eXp World Holdings fournit aux professionnels immobiliers l’opportunité unique d’obtenir des primes en actions en fonction de leurs objectifs de production et de leur contribution à la croissance globale de l’entreprise. eXp World Holdings et ses entreprises offrent une gamme complète de solutions technologiques en matière de courtage et d’immobilier, y compris son modèle innovant de courtage résidentiel et commercial, ses services professionnels, ses outils de collaboration et son développement personnel. Le service de courtage basé sur le cloud est alimenté par Virbela, une plateforme 3D immersive profondément sociale et collaborative, permettant aux agents d’être plus connectés et productifs. SUCCESS® Enterprises, ancrée par le magazine SUCCESS® et ses propriétés médiatiques connexes, a été créée en 1897 et est une marque ainsi qu’une publication de premier plan dans le domaine du développement personnel et professionnel.

Pour tout complément d’information, veuillez consulter le site https://expworldholdings.com.

Énoncés prospectifs

Les énoncés contenus dans les présentes peuvent inclure des énoncés de futures attentes et d’autres énoncés prospectifs se basant sur les opinions et suppositions actuelles de la direction et impliquent des risques connus et inconnus ainsi que des incertitudes pouvant causer une différence substantielle entre les résultats, performances ou événements réels et ceux exprimés ou sous-entendus dans ces énoncés. Des exemples de ces énoncés prospectifs comprennent, mais sans s’y limiter, la disponibilité de programmes d’incitation sur les marchés internationaux et la future valeur des programmes d’incitation financière. Ces énoncés prospectifs sont valables uniquement à la date indiquée dans les présentes, et la société n’assume aucune obligation de les réviser ou de les mettre à jour. Ces énoncés ne sont pas des garanties de performances futures. Des facteurs importants pouvant causer une différence substantielle et défavorable entre les résultats réels et ceux exprimés dans les énoncés prospectifs comprennent les changements commerciaux ou d’autres conditions du marché ; la difficulté de maintenir la hausse des dépenses à des niveaux modestes tout en augmentant les recettes ; et les autres risques détaillés de temps à autre dans les dépôts de la société auprès de la Securities and Exchange Commission, y compris, sans s’y limiter, le rapport trimestriel le plus récemment déposé sur formulaire 10-Q et le rapport annuel sur formulaire 10-K.

Contact des relations avec les médias :

eXp World Holdings, Inc.
mediarelations@expworldholdings.com

Contact des relations avec les investisseurs :

Denise Garcia
investors@expworldholdings.com

Une photo accompagnant ce communiqué de presse est disponible à l’adresse https://www.globenewswire.com/NewsRoom/AttachmentNg/5ef130bf-acbf-422b-a1dc-ae586120d6b8

GlobeNewswire Distribution ID 8967604